Why the study?
Does enalapril improve haemodynamic parameters in patients with primary hypertension?
Does enalapril improve haemodynamic parameters in patients with primary hypertension?
Enalapril effectively reduces blood pressure through decreased peripheral resistance while improving left ventricular systolic function and cardiac output in primary hypertension.
Answers are grounded in this paper and cite their sources.
Enalapril-associated haemodynamic gains in hypertension should not yet change practice; leaves open need for randomized confirmation.
After a run-in period on placebo, 15 patients with primary hypertension got antihypertensive treatment with enalapril single therapy during six weeks. Before and four hours after drug administration simultaneous non-invasive recordings of ECG, phonocardiogram and carotid pulse tracing or apexcardio-gram or impedance cardiogram were made. After six weeks' therapy the recordings were repeated 12 hours and four hours after dose intake. The results showed enalapril to be a potent antihypertensive agent with considerable effect already four hours after the first dose intake. The blood pressure reduction was explained by a decrease in total peripheral resistance, semiquantitatively measured with impedance cardiography. Cardiac output was significantly higher during long-term treatment than betore therapy started, due to a significant increase in stroke volume. Lef ventricular (LV) diastolic function was not altered but a considerable improvement in LV systolic function was achieved as judged from the systolic time intervals. Open questioning regarding side effects indicated good tolerance.
No takes yet. Share an insight, caveat, or question.
Wikstrand et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: